Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EQUIFAX INCEFX · Entity 3235 | EVP, Chief Legal Officer | February 25, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EQUIFAX INC
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,598 |
Reported balance
After 2026-02-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-25 · Grant · Acquired 11,152 · Balance 28,598 F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 11,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002761 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,598 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 2,614 | $202.71 | $529,883.94 |
DisclosureSEC source: 0001225208-26-001775 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,446 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 4,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001775 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,060 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:09 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 260 | $204.86 | $53,263.60 |
DisclosureSEC source: 0001225208-25-009271 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,927 F1 · shares: The reported transaction involved the withholding of 260 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 01, 2025 Filed May 5, 2025 21:42 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 2,312 | $0.00 Strike: $260.61 | $0.00 |
DisclosureSEC source: 0001225208-25-004742 · doc4.xml · derivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,312 Underlying: Common Stock · 2,312 shares Expires 2035-05-01 F3 · derivative.exercise_date: Equity award granted under the Company's long-term incentive plan in connection with the reporting person's appointment to the role of Executive Vice President, Chief Legal Officer. The option vests in three equal annual increments beginning 5/1/2026. Read SEC document |
| May 01, 2025 Filed May 5, 2025 21:42 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 720 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004742 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,163 F1 · security: Equity award granted under the Company's long-term incentive plan in connection with the reporting person's appointment to the role of Executive Vice President, Chief Legal Officer. The award of restricted stock units vests 100% on 5/1/2028. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,396 | $253.00 | $353,188.00 |
DisclosureSEC source: 0001225208-25-001651 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,434 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001651 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,830 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,670 | $0.00 Strike: $252.90 | $0.00 |
DisclosureSEC source: 0001225208-25-001583 · doc4.xml · derivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,670 Underlying: Common Stock · 6,670 shares Expires 2035-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001583 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,965 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 4,832 | $0.00 Strike: $191.44 | $0.00 |
DisclosureSEC source: 0001225208-24-007637 · doc4.xml · derivative · entry 5 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,832 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 3,830 | $0.00 Strike: $175.48 | $0.00 |
DisclosureSEC source: 0001225208-24-007637 · doc4.xml · derivative · entry 4 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,830 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 7,111 | $273.60 | $1,945,569.60 |
DisclosureSEC source: 0001225208-24-007637 · doc4.xml · nonDerivative · entry 3 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,875 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 3,830 | $175.48 | $672,088.40 |
DisclosureSEC source: 0001225208-24-007637 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 4,832 | $191.44 | $925,038.08 |
DisclosureSEC source: 0001225208-24-007637 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 4,815 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001225208-24-006561 · doc4.xml · derivative · entry 6 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,815 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,951 | $228.29 | $673,695.59 |
DisclosureSEC source: 0001225208-24-006561 · doc4.xml · nonDerivative · entry 5 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $227.69 to $228.67, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,647 | $228.97 | $377,112.11 |
DisclosureSEC source: 0001225208-24-006561 · doc4.xml · nonDerivative · entry 4 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,284 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.69 to $229.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 109 | $231.04 | $25,182.82 |
DisclosureSEC source: 0001225208-24-006561 · doc4.xml · nonDerivative · entry 3 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,931 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 108 | $230.04 | $24,844.22 |
DisclosureSEC source: 0001225208-24-006561 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,040 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.03 to $230.10, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 4,815 | $149.53 | $719,986.95 |
DisclosureSEC source: 0001225208-24-006561 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 4,280 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · derivative · entry 7 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,815 Underlying: Common Stock · 4,280 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,507 | $239.20 | $599,679.16 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · nonDerivative · entry 6 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,333 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $238.70 to $239.67, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 712 | $236.86 | $168,641.26 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · nonDerivative · entry 5 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,840 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $236.545 to $237.525, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 614 | $240.05 | $147,390.95 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · nonDerivative · entry 4 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,552 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $239.695 to $240.58, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 311 | $235.58 | $73,264.23 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · nonDerivative · entry 3 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $235.035 to $235.80, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 136 | $237.92 | $32,357.64 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,477 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $237.605 to $238.04, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:39 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 4,280 | $149.53 | $639,988.40 |
DisclosureSEC source: 0001225208-24-006427 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/23/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:49 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,599 | $255.78 | $408,992.22 |
DisclosureSEC source: 0001225208-24-002069 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,310 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:49 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002069 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,909 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 5,484 | $0.00 Strike: $249.18 | $0.00 |
DisclosureSEC source: 0001225208-24-001933 · doc4.xml · derivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,484 Underlying: Common Stock · 5,484 shares Expires 2034-02-09 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001933 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,446 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,148 | $209.13 | $240,086.29 |
DisclosureSEC source: 0001225208-23-010348 · doc4.xml · nonDerivative · entry 5 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,734 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $208.69 to $209.58, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 264 | $206.85 | $54,609.30 |
DisclosureSEC source: 0001225208-23-010348 · doc4.xml · nonDerivative · entry 4 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,882 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $206.285 to $207.235, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 255 | $207.91 | $53,015.80 |
DisclosureSEC source: 0001225208-23-010348 · doc4.xml · nonDerivative · entry 3 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $207.58 to $208.37, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 215 | $209.81 | $45,110.10 |
DisclosureSEC source: 0001225208-23-010348 · doc4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,401 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $209.78 to $209.905, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:29 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 118 | $205.36 | $24,232.00 |
DisclosureSEC source: 0001225208-23-010348 · doc4.xml · nonDerivative · entry 1 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,616 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $205.02 to $205.37, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 7,543 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · derivative · entry 14 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,543 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 3,378 | $0.00 Strike: $134.58 | $0.00 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · derivative · entry 13 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,378 shares Expires 2026-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F10 · derivative.exercise_date: The option vested in three equal annual increments beginning 9/30/2017. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 6,238 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · derivative · entry 12 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,238 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 4,326 | $0.00 Strike: $121.35 | $0.00 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · derivative · entry 11 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,326 shares Expires 2028-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F9 · derivative.exercise_date: The option vested in three equal annual increments beginning 3/5/2019. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 5,403 | $201.03 | $1,086,162.39 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 10 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,734 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F8 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $200.66 to $201.58, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,577 | $200.13 | $515,737.07 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 9 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,137 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $199.66 to $200.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 10,114 | $199.02 | $2,012,845.80 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 8 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,714 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $198.64 to $199.605, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,902 | $198.36 | $575,637.53 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 7 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,828 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $197.64 to $198.63, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 265 | $196.77 | $52,145.06 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 6 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,730 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $196.495 to $197.16, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 224 | $195.02 | $43,684.35 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 5 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,995 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $195.01 to $195.02, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 7,543 | $138.45 | $1,044,328.35 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 4 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 3,378 | $134.58 | $454,611.24 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 3 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 6,238 | $127.37 | $794,534.06 |
DisclosureSEC source: 0001062993-23-021106 · form4.xml · nonDerivative · entry 2 Houston Julia A · CIK 0001464568 · EVP, Strategy & Mktg Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 8/16/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.